Company Filing History:
Years Active: 2005-2008
Title: Kevin Edward Henegar: Innovator in Pharmaceutical Chemistry
Introduction
Kevin Edward Henegar is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on amino acids that have therapeutic applications.
Latest Patents
Henegar holds a total of 3 patents. His latest patents focus on amino acids with affinity for the α2δ-protein. These patents disclose certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. The compounds and their pharmaceutically acceptable salts are useful in treating a variety of psychiatric, pain, and other disorders. Additionally, the patents include methods for making these β-amino acids.
Career Highlights
Throughout his career, Henegar has worked with prominent companies in the pharmaceutical industry. He has been associated with Warner-Lambert Company and Agouron Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Henegar has collaborated with notable professionals in his field, including Peter Garth Blazecka and Joseph Richard Bozelak. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Kevin Edward Henegar's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of various disorders, showcasing the importance of innovation in healthcare.